Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Mibavademab in adult women with Functional Hypothalamic Amenorrhea, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mibavademab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Functional Hypothalamic Amenorrhea (FHA) | Phase 2 | Status: RECRUITING